As one of the nutraceutical industry’s most prestigious global platforms, Vitafoods Europe recognises excellence in scientific advancement and market-leading solutions. This win marks a significant milestone for Ashwa.30, coming shortly after its recent success at the Vitafoods India 2026 Innovation Awards, further cementing its position as a global leader in the ashwagandha market.
The Science Behind the Success
Ashwa.30 is a 100% root-derived Ashwagandha extract, uniquely standardised to a 30% Ashwa Bio-Active Complex. This profile includes:
- 15% Withanolides: Supports stress and cortisol balance.
- 15% ATP Actives: Specifically targeted for energy, endurance cellular vitality and longevity.
Developed using cutting-edge BOT (Bio-Optimized Technology), Ashwa.30 offers a solution requiring only a 30mg daily dose.
Redefining the Active Lifestyle Category
The award recognizes Ashwa.30’s ability to meet the rigorous demands of modern consumers. Backed by seven clinical validations, the ingredient is scientifically proven to address the core pillars of an active lifestyle:
"This recognition reflects the growing global relevance of clinically validated botanical solutions," said a spokesperson for Natural Remedies. "Our achievement at Vitafoods Europe reinforces Ashwa.30’s scientific credibility, its differentiated positioning in a crowded market, and its profound impact across global regions."
Setting a New Standard
While traditional ashwagandha extracts often require much higher dosages, Ashwa.30’s low-dose efficacy makes it a versatile choice for manufacturers looking to innovate in the supplements, functional foods, and beverage sectors. This second consecutive award in 2026 underscores Natural Remedies' commitment to bridging the gap between ancient botanical wisdom and modern clinical science.